Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #180983 on Biotech Values
tony111
08/06/14 12:01 AM
#180986 RE: mcbio #180983
caravon
08/06/14 9:27 AM
#180995 RE: mcbio #180983
The data in the P3 MARQUEE NSCLC trial has still not matured for the EGFR mutant sub-group.
With recent restructuring, cash runway has been extended another year (into 2017 now).
bladerunner1717
10/31/14 2:10 PM
#183402 RE: mcbio #180983